Negócios · 29/05/19971 min de leitura
Oral Dosage Form New Animal Drugs; Orbifloxacin Tablet
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Schering-Plough Animal Health. The NADA provides for use of orbifloxacin for dogs for management of diseases associated with bacteria susceptible to orbifloxacin.